# SHR2554 as Maintenance Therapy in Patients With Peripheral T-cell Lymphoma

> **NCT07347288** · PHASE2 · NOT_YET_RECRUITING · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 30 (estimated)

## Conditions studied

- PTCL

## Interventions

- **DRUG:** SHR2554 Tablets

## Key facts

- **NCT ID:** NCT07347288
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2029-02
- **Final completion:** 2029-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07347288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07347288, "SHR2554 as Maintenance Therapy in Patients With Peripheral T-cell Lymphoma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07347288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*